Financial Data and Key Metrics Changes - Total revenue for Q4 2025 was $103.9 million, up from $97.9 million in Q4 2024, while full-year revenue for 2025 totaled $370.5 million, a 6% decrease compared to 2024 [8][9] - Gross margins for Q4 2025 were 78% on a GAAP basis, down from 79% in Q4 2024, while non-GAAP gross margins were 79% for both Q4 and full year 2025 [9][11] - GAAP diluted earnings per share for Q4 2025 were $0.42, compared to $1.14 in Q4 2024, and $1.43 for the full year 2025, down from $2.25 in 2024 [11][12] Business Line Data and Key Metrics Changes - Revenue from consumables and services increased slightly compared to last year, indicating early signs of stabilization in patient activity [4] - Minimally invasive technology platforms accounted for 76% of total revenues in Q4 2025, while consumables and services represented 22% of revenue, up from 20% in 2024 [9][10] Market Data and Key Metrics Changes - Sales outside the U.S. totaled $48.5 million in Q4 2025, representing 47% of total sales and a 38% increase compared to Q4 2024, driven primarily by Europe [9] - For the full year 2025, sales outside the U.S. accounted for $171.8 million, or 46% of total sales, representing a 15% increase compared to 2024 [9] Company Strategy and Development Direction - The company views 2026 as a stabilization year following a prolonged period of industry softness, with plans to continue innovating and introducing new platforms [4][6] - A specialized sales team has been established for the Envision platform, aimed at increasing penetration and improving sales productivity [5] - The company plans to launch two new platforms in 2026, including a Korean-made Pico laser device and a device combining new Morpheus technology with Erbium YAG laser [6] Management's Comments on Operating Environment and Future Outlook - Management noted that the industry has not yet fully recovered from the global economic slowdown, with demand in North America remaining below historical levels, but there are early signs of stabilization [7] - The CEO mentioned that interest rates starting to come down could positively impact leasing packages for capital equipment purchases [17] Other Important Information - The company returned $127.4 million to shareholders through a disciplined share repurchase program [13] - The board of directors is exploring strategic alternatives to improve company value, having engaged Bank of America for assistance [20] Q&A Session Summary Question: What signs suggest improving trends in the market? - Management noted a slight increase in procedures and sales in consumables, along with declining interest rates as positive indicators [17] Question: Can you provide updates on strategic alternatives? - The board is considering several strategic alternatives and has engaged Bank of America for assistance, with management not directly involved in the process [20] Question: What are the expectations for gross margins and EBIT margins? - Management indicated that new product launches, particularly lasers, may impact gross margins, and guidance is conservative based on past experiences [27][28] Question: How is the ApexRF platform performing? - The ApexRF platform is being sold alongside other products without a specialized sales team, and management is awaiting FDA indications before pushing it further [72] Question: What is the contribution of new product launches for 2026? - Two new products are expected to be launched in 2026, with significant marketing efforts planned, although specific financial contributions are not yet provided [41]

Financial Data and Key Metrics Changes - In Q4 FY2025, net sales were $752 million, exceeding the previous outlook, with adjusted EBITDA of $71 million, impacted by one-time inventory adjustments and non-routine items [6][11][12] - For the full year, net sales reached $2.9 billion, with adjusted EPS at $6.05 and adjusted EBITDA totaling $386 million [12] - The company reported a net loss of $54 million in Q4, which included a $19 million non-cash goodwill impairment charge and a $67 million impairment charge related to HDPE assets [11][12] Business Line Data and Key Metrics Changes - Organic volume growth was 1.4% in Q4, with significant contributions from plastic pipe conduit and finished products, particularly PVC, fiberglass, and HDPE, all showing double-digit growth [6][8] - The electrical segment generated net sales of $519 million, with organic volume growth contributing $7 million, while the Safety and Infrastructure (S&I) segment saw a 4% increase in net sales compared to the prior year [15][16] Market Data and Key Metrics Changes - The company anticipates mid-single digit volume growth in FY2026, driven by expected growth across all product areas, particularly in construction end markets such as data centers, healthcare, and renewable energy [10][17] - The demand for electricity is projected to grow at a compound annual growth rate of 2.6% through 2035, driven by the expansion of data centers and renewable energy adoption [19][20] Company Strategy and Development Direction - The board is exploring strategic alternatives, including a potential sale or merger of the entire company, to enhance focus on Atkore's core electrical infrastructure portfolio [5][4] - The company plans to cease operations at three manufacturing facilities and divest non-core assets to improve financial returns and focus on its electrical infrastructure portfolio [5][9] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about growth in construction end markets for FY2026, particularly in data centers and renewable energy, while acknowledging challenges in pricing versus cost dynamics [10][50] - The company aims to generate strong cash flows and maintain a healthy balance sheet to support strategic opportunities and return capital to shareholders [9][18] Other Important Information - The company has achieved three consecutive years of organic volume growth, with a total volume increase of approximately 1% in FY2025 [8][13] - Cash flow generation remains a strength, with $144 million returned to shareholders through share repurchases and dividends [9] Q&A Session Summary Question: Guidance for fiscal 2026 and pricing dynamics - Management confirmed expectations of mid-single digit volume growth for FY2026, with potential pricing benefits driven by sequential price increases in steel conduit and other products [26][27] Question: Strategic review and divestment magnitude - The board is exploring various outcomes, including the sale of the entire company, with ongoing discussions regarding the HDPE business and other non-core assets [36][37] Question: Cost savings initiatives - Expected annualized cost reductions of $10 million to $12 million from the closure of three plants, with ongoing efforts to identify further cost-saving opportunities [39][41] Question: Headwinds from imports and pricing - Management acknowledged continued price versus cost headwinds, estimating around $50 million in unmitigated headwinds for FY2026, with expectations for improvement in the second half of the year [49][50] Question: Impact of data centers on growth - Management noted that while data centers are a growing market, the overall impact on growth will depend on the execution of larger mega projects and existing product lines [56][60] Question: Intent to run the business for cash and dividend policy - Management confirmed no current intention to suspend dividends, emphasizing a commitment to maintaining a strong balance sheet while managing capital expenditures [80][82] Question: Seasonal dynamics affecting guidance - Management explained that the first quarter typically experiences a seasonal decline, with expectations for stronger performance in the second half of the fiscal year due to ongoing investments and project ramp-ups [89][90]

Financial Data and Key Metrics Changes - The meeting discussed the approval of a reverse stock split proposal and an increase in authorized common stock, indicating a strategic move to enhance shareholder value [12][22]. Business Line Data and Key Metrics Changes - Specific financial performance metrics for different business lines were not disclosed during the meeting, as management indicated they could not answer questions related to third-quarter performance [10]. Market Data and Key Metrics Changes - The company acknowledged a significant disconnect between its asset value and public market valuation, prompting discussions about exploring strategic alternatives [12]. Company Strategy and Development Direction - The Board and management are actively pursuing all options to maximize shareholder value, including the potential sale of the company [12]. - The decision to seek a reverse stock split was strategically aligned with ensuring compliance with NASDAQ requirements, reflecting a focus on long-term shareholder value [13]. Management Comments on Operating Environment and Future Outlook - Management emphasized that forward-looking statements made during the meeting are based on current expectations and are subject to risks and uncertainties that could lead to actual results differing materially from projections [11]. Other Important Information - The meeting was conducted virtually, and shareholders were encouraged to submit questions via an online platform, with a commitment to address as many as possible within the allotted time [3][10]. Q&A Session Summary Question: Has the Board engaged advisors to explore strategic alternatives to maximize value for shareholders? - The Board and management are pursuing all options to maximize shareholder value [12]. Question: Can the Board explain the strategic rationale behind the reverse stock split decision and its timing? - The decision was based on ensuring compliance with NASDAQ processes and timelines, allowing for the option of a reverse stock split within the grace period [13].